SecBot SecBot
424B4 ·Filed Mar 6, 2026

MDLN

Medline Inc.
NEUTRAL
Impact 5/10
Horizonmonths Processed8mo ago SEC0001193125-26-096456
Prospectus supplement
Actionable Insight • Neutral

Traders should note that this is a secondary offering, so the company's balance sheet is not directly impacted by the cash raised. However, the significant tax receivable agreement liability is a long-term financial obligation that could affect future cash flows. The discount to the market price may create short-term downward pressure on the stock, but the fundamental business operations remain unchanged.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$43.41
T+0 close · Mar 6, 2026 · via day close
Latest settled
−23.54%
T+60 · $33.19
Vs SPY
−35.53%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 9 $43.41entry
  2. T+1 · 8mo ago −1.22%α −1.04% · $42.88
  3. T+5 · 8mo ago −3.82%α −2.47% · $41.75
  4. T+20 · 7mo ago −0.67%α +2.14% · $43.12
  5. T+60 · 6mo ago −23.54%α −35.53% · $33.19

Executive Summary

Medline Inc. (MDLN) is conducting a secondary offering where selling stockholders are selling 75 million shares at $41.00 per share, raising $3.075 billion. The offering represents a 9.1% discount to the prior closing price of $42.88. Medline Inc. will not receive any proceeds from this sale. The transaction involves existing owners exchanging Common Units for shares to sell, and it triggers significant tax basis adjustments under a tax receivable agreement, with estimated future tax benefit payments of up to $11.14 billion.

Key Facts

  • Selling stockholders are offering 75 million shares of MDLN Class A common stock.
  • The public offering price is $41.00 per share, with Medline Inc. receiving no proceeds.
  • The offering price represents a 9.1% discount to the prior closing price of $42.88.
  • The transaction triggers a tax basis step-up, with an estimated $11.14 billion in future payments under the tax receivable agreement.
  • The underwriters' option to purchase up to an additional 11.25 million shares is not included in the initial offering size.
  • The offering is being conducted in compliance with FINRA Rule 5121 due to a conflict of interest involving underwriters who are also major shareholders.

Financial Impact

The offering raises $3.075 billion for the selling stockholders. The tax receivable agreement could result in future payments of up to $11.14 billion, which is a significant long-term liability for Medline Inc.

cashFlowdilutiondebt

Risk Factors

  • The tax receivable agreement creates a substantial long-term liability of up to $11.14 billion.
  • The offering increases the public float, which could lead to increased stock price volatility.
  • The conflict of interest involving underwriters who are also major shareholders could raise governance concerns.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001193125-26-096456
Document: 0001193125-26-096456-index-headers.html0001193125-26-096456
Document: 0001193125-26-096456-index.html0001193125-26-096456
Document: 0001193125-26-096456.txt0001193125-26-096456

Track record

30 reports on MDLN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.47 −8.43% settles Nov 23
  2. Nov 16, 2026today S-1 Neutral 4/10 Entry price pending
  3. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $42.00 Now $39.47 −6.02% settles Nov 23
  4. Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.47 −6.02% settles Nov 23
  5. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.47 −3.05% ▼ −3.78% −2.09% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  7. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.47 −2.18% ▲ +4.49% +5.40% vs SPY
  8. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.47 −15.78% ▼ −20.01% −20.59% vs SPY
  9. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.47 +22.88% ▲ +23.41% +26.12% vs SPY
  10. Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.47 −13.16% ▲ +8.26% +8.96% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (12h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 6, 2026